During the past decade, Tottori University Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 11 clinical trials were completed, i.e. on average, 36.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 8 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tottori University Hospital" #1 sponsor was "Loxo Oncology, Inc." with 4 trials, followed by "Chugai Pharmaceutical" with 2 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Janssen Pharmaceutical K.K." with 2 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tottori University Hospital" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Maruishi Pharmaceutical" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Tottori University Hospital" are "Non-Small Cell Lung Cancer" (4 trials), "Heart Failure" (3 trials), "Nervous System Diseases" (3 trials), "Colon Cancer" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Tottori University Hospital" in a lesser frequency.

Most popular intervention types in "Tottori University Hospital" are "Drug" (36 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Selpercatinib" (3 trials), "carboplatin" (3 trials), "paclitaxel" (3 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tottori University Hospital" are 39 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Tottori University Hospital". undefined are not yet recruiting, 10 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Tottori University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tottori University Hospital, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".